Klkb21 Inhibitors
Klkb21 inhibitors are chemical compounds that specifically target and inhibit the activity of the Klkb21 enzyme, which is a kallikrein-related peptidase. Kallikreins are a subgroup of serine proteases, a class of enzymes known for their ability to cleave peptide bonds in proteins. Klkb21, in particular, plays a role in the complex regulatory processes of proteolysis, which involves the breakdown of proteins into smaller polypeptides or amino acids. Inhibitors of Klkb21 function by binding to the enzyme's active site or by altering its conformation, thereby preventing it from interacting with its substrates. The inhibition of Klkb21 activity can lead to a reduction in proteolytic activity, which may be critical in modulating various physiological pathways where this enzyme is involved, such as inflammatory responses and blood coagulation.
The chemical structure of Klkb21 inhibitors is typically designed to mimic the natural substrates of the enzyme, allowing them to compete effectively for binding. These compounds often contain functional groups that can interact with the active serine residue in the enzyme's catalytic triad, which includes serine, histidine, and aspartate. Structural studies of Klkb21 inhibitors have revealed that these molecules are highly specific, often incorporating peptidomimetic elements to ensure selective inhibition of Klkb21 without affecting other related kallikrein enzymes. This specificity is achieved through the careful design of the molecular scaffold, which is optimized for binding affinity and stability. Furthermore, these inhibitors can exhibit various degrees of potency depending on their molecular interactions with Klkb21, including hydrogen bonding, hydrophobic interactions, and van der Waals forces.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Benzamidine is a reversible inhibitor of trypsin-like serine proteases and can inhibit Klkb21 by binding to its active site, which is typically specific for lysine or arginine residues on the substrate. This competitive inhibition can prevent Klkb21 from cleaving its natural substrates. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin, a small protein inhibitor, can inhibit Klkb21 by forming a reversible stoichiometric complex with serine proteases, blocking the access of substrates to the active site of Klkb21 and thereby inhibiting its function. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF covalently and irreversibly inhibits serine proteases by reacting with the serine residue in the active site of the enzyme. This results in the functional inhibition of Klkb21 by preventing it from hydrolyzing peptide bonds in proteins. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is a reversible inhibitor that targets serine and cysteine proteases. It inhibits Klkb21 by binding to the active site, preventing the cleavage of peptide bonds that the protease would normally perform. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin is a competitive inhibitor of aminopeptidases and can indirectly inhibit Klkb21 by altering peptide catabolism, potentially leading to an accumulation of peptides that may naturally inhibit Klkb21 activity by competing with its substrates. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
Phosphoramidon inhibits metalloproteases, which could lead to an accumulation of proteins or peptides that might otherwise be degraded. This inhibition can indirectly influence Klkb21 activity by altering the protein/peptide composition in the vicinity of Klkb21, potentially hindering its activity. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate Mesilate is a serine protease inhibitor that can inhibit Klkb21 by directly binding to the active site, preventing substrate access and thus inhibiting the proteolytic activity of Klkb21. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat Mesilate inhibits a variety of serine proteases and can inhibit Klkb21 by forming a stable complex with the enzyme, which prevents substrate cleavage. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Camostat Mesilate is known to inhibit serine proteases and can inhibit Klkb21 by binding to its active site, thereby blocking substrate entry and inhibiting the enzyme's function. | ||||||
Sivelestat | 127373-66-4 | sc-203938 | 1 mg | $105.00 | 2 | |
Sivelestat selectively inhibits neutrophil elastase; however, it can inhibit Klkb21 by a similar mechanism of action, binding to the active site of the enzyme and preventing the hydrolysis of peptide bonds. | ||||||